ORMAT TECHNOLOGIES INC
ORANYSE🏆 #1170 by market capEarnings Nov 4 · PostUS Equity
$91.70▲ $0.03 (+0.03%)
Latest quoteTrack ORA
Get earnings, price moves & breaking news on Telegram
24h▲ 0.0%
7d▲ 4.1%
14d▲ 2.4%
30d▲ 0.4%
ytd▼ 17.0%
1y▼ 14.5%
🏦Market Cap
$5.64B
Small Cap
📈Revenue Growth (YoY)
12.5%
Healthy
📊Gross Margin
27.9%
Moderate
💵FCF Margin
-22.3%
Thin
⚖️P/S Ratio
4.7x
Fair
Otter Score
52
Fair
ORMAT TECHNOLOGIES INC
ORAAnalyst Ratings
Price
$91.70
Total
19
Raised
2
Lowered
7
Avg PT
$124.71
H / L
$145 / $100
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
JP Morgan | Reiterated | Neutral | 2026-10-19 | $97.00 | +5.80% |
UBS | Downgraded | Buy → Neutral | 2026-10-01 | $100.00 | +9.10% |
RBC Capital | Reiterated | Outperform | 2026-09-09 | — | — |
Oppenheimer | Reiterated | Outperform | 2026-09-09 | $145.00 | +58.10% |
Bernstein | Upgraded | Underperform → Market Perform | 2026-09-04 | $112.00 | +22.10% |
Barclays | Reiterated | Overweight | 2026-08-10 | $122.00 | +33.00% |
Piper Sandler | Reiterated | Overweight | 2026-05-18 | $142.00 | +54.90% |
Baird | Reiterated | Outperform | 2026-02-27 | — | — |
Citigroup | Reiterated | Neutral | 2026-02-18 | — | — |
Jefferies | Downgraded | Buy → Hold | 2026-02-13 | $117.00 | +27.60% |
TD Cowen | Upgraded | Hold → Buy | 2026-01-09 | — | — |
Roth Capital | Reiterated | Buy | 2025-11-05 | $135.00 | +47.20% |
Roth MKM | Reiterated | Buy | 2024-11-08 | — | — |
B of A Securities | Downgraded | Buy → Neutral | 2022-01-26 | — | — |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2019-10-24 | — | — |
Guggenheim | Downgraded | Buy → Neutral | 2018-06-13 | — | — |
Avondale Partners | Downgraded | Outperform → Market Perform | 2015-11-05 | — | — |
Jacob Securities | Reiterated | Hold | 2013-11-07 | — | — |
Ardour Capital | Downgraded | Accumulate → Hold | 2013-08-08 | — | — |
Institution
JP Morgan
Reiterated · Neutral · 2026-10-19
$97.00
+5.80%
UBS
Downgraded · Buy → Neutral · 2026-10-01
$100.00
+9.10%
RBC Capital
Reiterated · Outperform · 2026-09-09
—
—
Oppenheimer
Reiterated · Outperform · 2026-09-09
$145.00
+58.10%
Bernstein
Upgraded · Underperform → Market Perform · 2026-09-04
$112.00
+22.10%
Barclays
Reiterated · Overweight · 2026-08-10
$122.00
+33.00%
Piper Sandler
Reiterated · Overweight · 2026-05-18
$142.00
+54.90%
Baird
Reiterated · Outperform · 2026-02-27
—
—
Citigroup
Reiterated · Neutral · 2026-02-18
—
—
Jefferies
Downgraded · Buy → Hold · 2026-02-13
$117.00
+27.60%
TD Cowen
Upgraded · Hold → Buy · 2026-01-09
—
—
Roth Capital
Reiterated · Buy · 2025-11-05
$135.00
+47.20%
Roth MKM
Reiterated · Buy · 2024-11-08
—
—
B of A Securities
Downgraded · Buy → Neutral · 2022-01-26
—
—
Cowen & Co.
Downgraded · Outperform → Market Perform · 2019-10-24
—
—
Guggenheim
Downgraded · Buy → Neutral · 2018-06-13
—
—
Avondale Partners
Downgraded · Outperform → Market Perform · 2015-11-05
—
—
Jacob Securities
Reiterated · Hold · 2013-11-07
—
—
Ardour Capital
Downgraded · Accumulate → Hold · 2013-08-08
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space